A Study of LY3841136 in Healthy and Overweight Participants

Completed · Phase 1 · Has a placebo group

Conditions studied: Obesity, Healthy

In brief

The main purpose of this study is to evaluate the safety and tolerability of LY3841136 in healthy and overweight participants. Blood tests will be performed to check how much LY3841136 gets into the bloodstream and how long it takes the body to eliminate it. This is a 2-part study and may last up to 14 and 28 weeks for each participant and may include 7 and 19 visits in parts A and B, respectively.

Key facts

Study ID
NCT05295940
Run by
Eli Lilly and Company
People needed
148
Starts
2022-03-30
Expected to finish
2024-01-25
Last updated by the study team
2024-04-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.